Cytokine analysis in multiple sclerosis by competitive RT-PCR: A decreased expression of IL-10 and an increased expression of TNF-α in chronic progression

Multiple Sclerosis

Volumn 5, Issue 5, 1999, Pages 342-348

  Huang, Wen Xin ^a   Huang, Ping ^a   Link, Hans ^a   Hillert, Jan ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Biosciences at Novum   (Sweden)

Author keywords

Interferon gamma; Interleukin 10; Interleukin 4; Multiple sclerosis; Reverse transcription polymerase chain reaction (RT PCR); Tumor necrosis factor alpha

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032744256     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245899678846401     Document Type: Article

References (32)

1. Link H. (1998) The cytokine storm in multiple sclerosis. Multiple Sclerosis 4: 12-15.
2. Olsson T. (1994) Multiple Sclerosis: cerebrospinal fluid. Ann Neurol 36 (Suppl): S100-S102.
3. Hauser SL et al. (1990) Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of IL-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735-1739.
4. Sharief MK, Hentges R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467-472.
5. Tsukada N et al. (1991) Tumor necrosis factor and interleukin-1 in CSF and sera of patients with multiple sclerosis. J Neurol Sci 104: 230-234.
6. Sharief MK, Thompson EJ. (1992) Distribution of cerebrospinal fluid oligoclonal IgM bands in neurological diseases: a comparison between agarose electrophoresis and isoelectric focusing. J Neurol Sci 109: 83-87.
7. Franciotta DM et al. (1989) Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis. Ann Neurol 26: 787-789.
8. Gallo P, Piccinno MG, Krzaliuc L, Tavolato B. (1989) Tumor necrosis factor alpha (TNF-α) and neurological disease. Failure in detecting TNF-α in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex and brain tumors. J Neuroimmunol 23: 41-44.
9. Maimone D, Gregory S, Arnason BGW, Reder AT. (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32: 67-74.
10. Peter JB, Boctor FN, Tourtellotte WW. (1991) Serum and CSF levels of IL-2, sIL-2, sIL-2R, TNF-α, and IL-1β in chronic progressive multiple sclerosis: expected lack of clinical utility. Neurology 41: 121-123.
11. Shaw CE, Dunbar PR, Macaulay HA, Neale TJ. (1995) Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis during clinical remission. J Neurol 242: 53-58.
12. Heney D, Whicher JT. (1995) Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement. Ann Clin Biochem 32 (Pt 4): 358-368.
13. Feldmann M, Brennan FM, Maini RN. (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14: 397-440.
14. Bendtzen K. (1989) Immune hormones (cytokines); pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 2: 177-189.
15. Link J et al. (1994) Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis. J Neuroimmunol 51: 185-192.
16. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
17. Chomcynski P, Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinum thiocyanate-phenolchloroform extraction. Anal Biochem 162: 156-159.
18. Celi FS, Zenilman ME, Shuldiner AR. (1993) A rapid and versatile method to synthesize internal standards for competitive PCR. Nucl Acids Res 21: 1047.
19. Olsson T et al. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Inv 86: 981-985.
20. Olsson T et al. (1992) Increased number of T cells recognizing multiple myelin basic protein epitomes in multiple sclerosis. Eur J Immunol 22: 1083-1087.
21. Link J et al. (1994) Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 44: 728-734.
22. Lu CZ, Jensen MA, Arnason BG. (1993) Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol 46: 123-128.
23. Link J et al. (1994) Increased transforming growth factor-β, interleukin 4 and interferon-γ in multiple sclerosis. Ann Neurol 36: 379-386.
24. Navikas V et al. (1995) Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 41: 171-178.
25. Rieckmann P et al. (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37: 82-88.
26. Barbara JA, Van ostade X, Lopez A. (1996) Tumor necrosis factor-alpha (TNF-α): The good, the bad and potentially very effective. Immunol Cell Biol 74: 434-443.
27. Hofman FM, Hinton DR, Johnson K, Merill JE. (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170: 607-612.
28. Salmaggi A et al. (1996) Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J Neurol 243: 13-17.
29. Musette P et al. (1996) The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis. Res Immunol 147: 435-441.
30. Lalani I, Bhol K, Ahmed AR. (1997) Interleukin-10: biology, role in inflammation and autoimmunity. Annals of Allergy, Asthma, & Immunology 79: 469-483.
31. Gazzinelli RT et al. (1996) In the absence of endogenous IL-10 mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma, and TNF-alpha. J Immunol 157: 798-805.
32. de Vries JE. (1995) Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27: 537-541.